1. Home
  2. Research
  3. Research Groups
  4. Multiple Sclerosis

Multiple Sclerosis

Search for publications

Only original articles, editorials, guidelines.

  • González-Gay MÁ, Gómez-Bernal F, Quevedo-Abeledo JC, Tejera-Segura B, Gómez-Moreno C, García-Barrera E, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.

    Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

    AUTOIMMUNITY . 59(1): 2701071-2701071.

    [doi:10.1080/08916934.2026.2701071]

  • Díez-Cirarda M, Matías-Guiu JA, Ruiz-Ortiz M, Aladro Y, Cuevas C, Domingo-Santos Á, Galán Sánchez-Seco V, Labiano-Fontcuberta A, Gómez-López A, Salgado-Cámara P, Costa-Frossard L, Monreal E, Sainz de la Maza S, Matías-Guiu J, Gil-Martínez L, Yus-Fuertes M, Montero-Escribano P, Martínez-Ginés ML, Ayuso-Peralta L, Melero H, Malpica N, Benito-León J.

    Ventral attention network connectivity differentiates radiologically isolated syndrome from multiple sclerosis: a longitudinal resting-state fMRI study.

    AMERICAN JOURNAL OF NEURORADIOLOGY . 47(8): 2163-2171. Number of citations: 1

    [doi:10.3174/ajnr.A9212]

  • Cabañas Engenios G, Mena García N, Garay Albízuri P, Llanes Ferrer A, Sánchez Asensio A, Romero Ferro J, Gil Martinez L, Campos Jiménez M, Pastor González R, Rodríguez Jorge F, Sainz de la Maza S, Monreal Laguillo E, Villar LM, Masjuan Vallejo J, Costa-Frossard L, Chico García JL.

    Discontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control study.

    Multiple Sclerosis and Related Disorders . 112: 107343-107343.

    [doi:10.1016/j.msard.2026.107343]

  • Martin-Moro F, Alcoceba M, Romero S, Marquet-Palomanes J, Alonso-Castronuño D, Astibia-Mahillo B, Andreu R, Perez-Alonso R, Rodriguez-Martin E, De Ramon C, Solano I, Martin Garcia-Sancho A, Piris-Villaespesa M, Blanco O, Roldan-Santiago E, Garcia-Marco JA, Subira D, Navarro-Bailon A, Garcia-Cosio M, Garcia-Vela JA, Lopez-Jimenez J.

    Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis.

    MODERN PATHOLOGY . 39(7): 101009-101009.

    [doi:10.1016/j.modpat.2026.101009]

  • Macia-Villa C, Fernandez-Velasco JI, Ferre-Sanfrancisco M, Mendoza-Bravo DA, Ruiz-Bejerano AM, Ferrez-Hernandez C, Morell-Hita JL.

    Exploring the phenotypic expression of HLA-B27 in psoriatic arthritis.

    CLINICAL RHEUMATOLOGY . 45(6): 3399-3404.

    [doi:10.1007/s10067-026-08144-5]

  • Costa-Frossard L, Brieva L, García-Estévez DA, Martín-Martínez JM, Álvarez-Bravo G, Blasco-Quílez MR, Meca-Lallana JE, Calles-Hernández MC, Ramo Tello C, Muñoz-Fernández C, Barbero DE, López-Muñoz P, Prieto González JM, Candeliere-Merlicco A, Carmona O, Riancho J, Sola-Valls N, Carcelén-Gadea M, Borrega L, Gascón-Giménez F, Vilanova D, Pérez X, Villar LM.

    Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 27(11): .

    [doi:10.3390/ijms27114933]

  • Muñoz-Gómez S, Pariente-Rodríguez R, Chico-García JL, García de la Torre I, Navarro Caspistegui J, García-Domínguez JM, Schiaffino MT, Sánchez-Mateos P.

    Clinical and laboratory findings in patients with anti-myelin oligodendrocyte glycoprotein antibodies: experience from two tertiary hospitals in Madrid.

    Frontiers in Immunology . 17: 1809873-1809873.

    [doi:10.3389/fimmu.2026.1809873]

  • Chico-Garcia JL, Morales de la Prida M, Boix Lago A, García-Domínguez JM, Sepúlveda M, Martínez-Hernández E, Guasp M, Fonseca E, Calvi A, Alba-Isasi MT, Albertí B, Cid J, Lozano M, Charry P, Rodríguez-Jorge F, Sainz-Amo R, Sainz de la Maza S, Monreal E, Villar LM, Masjuan J, Valero-López G, Millán-Pascual J, Cuello JP, Palacios M, Gifreu Fraixinó A, Martínez-Gins ML, Álvarez Bravo G, Meca-Lallana JE, Costa-Frossard L, Blanco Y, Cabrera-Maqueda JM, Saiz A, Llufriu S.

    Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.

    Therapeutic Advances in Neurological Disorders . 19: .

    [doi:10.1177/17562864261440665]

  • González-Gay MÁ, Gómez-Bernal F, Heras-Recuero E, Quevedo-Abeledo JC, Torres-Roselló A, Almeida-Santiago C, de Vera-González A, Tejera-Segura B, Blázquez-Sánchez T, García-Barrera E, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.

    High-sensitivity serum interferon-a and interferon-? as immunometabolic mediators of metabolic syndrome in systemic lupus erythematosus.

    RHEUMATOLOGY . 65(5): .

    [doi:10.1093/rheumatology/keag235]

  • García Domínguez JM, María Villar L, Arrambide G, Blanco Y, Carmen Calles M, Casanova B, Castillo-Triviño T, Costa-Frossard França L, Eichau S, Hernández Pérez MÁ, Landete L, Meca Lallana J, Oreja-Guevara C, María Prieto J, Querol L, Belén Caminero A.

    Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases.

    Neurologia . 41(4): 501928-501928.

    [doi:10.1016/j.nrleng.2026.501928]

  • Miguela A, Huertas-Pons JM, Coll-Martinez C, Gifreu-Fraixinó A, Salavedra-Pont J, Comabella M, Villar LM, Gich J, Álvarez-Bravo G, Ramió-Torrentà L, Quiroga-Varela A.

    A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.

    Frontiers in Immunology . 17: 1802339-1802339.

    [doi:10.3389/fimmu.2026.1802339]

  • León-Cabrera D, Quevedo-Abeledo JC, Almeida-Santiago C, García-Barrera E, Villar LM, Quiroga-Colina P, Ocejo-Vinyals JG, Javier-Ormazábal A, González-Gay MÁ, Ferraz-Amaro I.

    Serum interleukin-8 levels relate to disease activity in patients with rheumatoid arthritis.

    Therapeutic Advances in Musculoskeletal Disease . 18: .

    [doi:10.1177/1759720X261436835]

  • Saposnik G, Solanes A, Monreal E, Sepúlveda M, Hernández MÁ, Cuello JP, Álvarez-Bravo G, Agüera-Morales E, Riancho J, Pérez-Sempere Á, Maurino J, Gómez-Ballesteros R.

    Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists.

    Multiple Sclerosis Journal-Experimental Translational and Clinical . 12(2): .

    [doi:10.1177/20552173261438268]

  • Macia-Villa C, Fernández-Velasco JI, Ferre-Sanfrancisco M, Mendoza-Bravo DA, Ruiz-Bejerano AM, Ferrez-Hernández C, Morell-Hita JL.

    HLA-Cw6 in Psoriatic Arthritis: Clinical Phenotype and Therapeutic Impact.

    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY . 32(3): 79-84.

    [doi:10.1097/RHU.0000000000002322]

  • Pérez-Sempere Á, García-Arcelay E, Pérez JC, Candeliere-Merlicco A, Orviz A, Martín-Martínez J, Piñar-Morales R, Álvarez-Rodríguez E, Pacheco-Cortegana EM, Borrega L, Casanova I, Caminero AB, Sánchez-Menoyo JL, Gómez-Gutiérrez M, Carmona O, Calles C, Hernández MÁ, López-Muñoz P, Bakdache F, Monreal E, González-Suárez I, Maurino J.

    Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease Knowledge.

    Journal of Personalized Medicine . 16(4): .

    [doi:10.3390/jpm16040185]

  • Dominguez-Mozo MI, Ruberto S, Rodríguez-García C, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Casanova-Peño I, Martínez-Ginés ML, García-Domínguez JM, Ortega-Madueño I, Alonso-Garrido A, Pérez de Villar G, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R.

    Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesis.

    Scientific Reports . 16(1): .

    [doi:10.1038/s41598-026-46208-3]

  • Ruberto S, Dominguez-Mozo MI, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Casanova-Peño I, González-Suárez I, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R.

    HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis.

    Frontiers in Immunology . 17: 1776117-1776117.

    [doi:10.3389/fimmu.2026.1776117]

  • Benito-León J, Díez-Cirarda M, Ruiz-Ortiz M, Aladro Y, Cuevas C, Domingo-Santos Á, Galán Sánchez-Seco V, Labiano-Fontcuberta A, Gómez-López A, Salgado-Cámara P, Costa-Frossard L, Monreal E, Sainz de la Maza S, Matías-Guiu J, Montero-Escribano P, Martínez-Ginés ML, Ayuso-Peralta L, Matías-Guiu JA.

    Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing-Remitting Multiple Sclerosis.

    Journal of Clinical Medicine . 15(6): .

    [doi:10.3390/jcm15062184]